Etomidate Injection
Product Images NDC 51662-1718

2 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 51662-1718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51662 1718 Structure)

Structure (51662 1718 Structure)
Chemical structure diagram of Etomidate, showing its molecular arrangement with labeled atoms including carbon, hydrogen, nitrogen, and oxygen in a specific configuration relevant to its composition as an intravenous injection drug.*
FDA Label Image

Vial (51662 1718 1 Vial Label)

Vial (51662 1718 1 Vial Label)
Etomidate Injection USP 40 mg per 20 mL (2 mg/mL) in a clear glass vial with a red and silver cap. The label states it is for intravenous use and indicates the vial contains 20 mL single dose. Distributed by HF Acquisition Co, LLC, Mukilteo, WA. Includes a barcode and Rx only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.